Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» United Therapeutics faces likely delay on FDA review for inhaled hypertension treatment
United Therapeutics faces likely delay on FDA review for inhaled hypertension treatment
United Therapeutics faces likely delay on FDA review for inhaled hypertension treatment
Submitted by
admin
on March 16, 2009 - 9:25am
Source:
Yahoo/AP
News Tags:
United Therapeutics
FDA
hypertension
Remodulin
Headline:
United Therapeutics faces likely delay on FDA review for inhaled hypertension treatment
Do Not Allow Advertisers to Use My Personal information
